Latest News & Features
article
Case concerns epilepsy drug patent and medical cannabis R&D collaboration | Dispute between Japanese and Irish pharma firms will be heard in London due to arbitration carve-out clause. 10 November 2022
Big Pharma
Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices. 10 November 2022
article
WIPR Diversity sat down with Kathi Vidal, director of the US Patent and Trademark Office, to talk about her bold plans to encourage more women into the field of patents, expand the bar and make the agency a great place to work. 8 November 2022
article
Spruson & Ferguson has hired litigator Katrina Crooks as a principal, who will join its office in Sydney. 8 November 2022
article
Humanitarian organisations censure leaked IP provisions within UK-India free trade agreement | “Excessive measures” would “drastically harm access” to affordable, lifesaving generic medicines from India. 8 November 2022
Americas
The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition. 7 November 2022
article
Counsel for Ventria sat down with Sarah Speight to explore their landmark win at the International Trade Commission, which led to a US ban for a Chinese company 3 November 2022
article
Patent law firm EIP has hired Pontus Falk as a partner at its recently opened Sweden office. 3 November 2022
Big Pharma
Cardiovascular ‘innovator’ snapped up as company strengthens medtech offering | Massachusetts-based Abiomed will become part of purchaser’s medtech division 2 November 2022
Generics
Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for generic manufacturers 1 November 2022